Stay updated on Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Merck sponsor details and IPD sharing resources were added, along with related informational links. The update expands the page with governance and data-sharing context for the trial.
    Difference
    82%
    Check dated 2026-08-15T20:52:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The results status is updated to 'Results Submitted,' replacing the previous 'No Results Posted,' and the page revision has been updated to v3.6.5 (replacing v3.6.4).
    Difference
    0.1%
    Check dated 2026-08-08T20:07:16.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added related topic tags for Melanoma and MedlinePlus Genetics to the page. These additions enhance discoverability and connect users to broader melanoma information and genetic resources without changing the study content.
    Difference
    0.1%
    Check dated 2026-08-01T18:10:35.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, indicating a newer version of the content, and the items Melanoma, related topics:, MedlinePlus Genetics, and Revision: v3.6.3 were removed from the page.
    Difference
    0.2%
    Check dated 2026-07-25T12:30:03.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added related topics entries for Melanoma and MedlinePlus Genetics to the study page's related topics section. This enhances navigational context by providing quick access to melanoma information and genetics resources.
    Difference
    0.1%
    Check dated 2026-07-18T09:20:25.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Melanoma was removed from the study’s condition listing. The related topics section, including MedlinePlus Genetics, was also deleted.
    Difference
    0.1%
    Check dated 2026-07-11T04:44:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.